PPARA and Glucose intolerance: Considering the well described dynamic plasticity of macrophages especially in terms of pregnancy related tolerance PPAR ligands could evolve to an interesting therapeutic agent by promoting the M2 phenotype and therefore improving pregnancy development and reducing glucose intolerance.